Continuing medical education
Pathogenic mechanisms of the anti-phospholipid antibodies
Mecanismos patogénicos de los anticuerpos antifosfolípidos
Laboratorio de Inmunología, Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Read
6543
Timeswas read the article
3047
Total PDF
3496
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 2 | 3 |
| 2025 5 | 108 | 61 | 169 |
| 2025 4 | 70 | 37 | 107 |
| 2025 3 | 38 | 38 | 76 |
| 2025 2 | 52 | 43 | 95 |
| 2025 1 | 56 | 86 | 142 |
| 2024 12 | 33 | 38 | 71 |
| 2024 11 | 44 | 88 | 132 |
| 2024 10 | 32 | 51 | 83 |
| 2024 9 | 37 | 29 | 66 |
| 2024 8 | 38 | 49 | 87 |
| 2024 7 | 32 | 44 | 76 |
| 2024 6 | 25 | 44 | 69 |
| 2024 5 | 27 | 36 | 63 |
| 2024 4 | 29 | 32 | 61 |
| 2024 3 | 20 | 35 | 55 |
| 2024 2 | 31 | 33 | 64 |
| 2024 1 | 21 | 25 | 46 |
| 2023 12 | 10 | 24 | 34 |
| 2023 11 | 19 | 26 | 45 |
| 2023 10 | 28 | 34 | 62 |
| 2023 9 | 19 | 48 | 67 |
| 2023 8 | 30 | 11 | 41 |
| 2023 7 | 16 | 35 | 51 |
| 2023 6 | 12 | 27 | 39 |
| 2023 5 | 21 | 12 | 33 |
| 2023 4 | 12 | 11 | 23 |
| 2023 3 | 17 | 28 | 45 |
| 2023 2 | 23 | 28 | 51 |
| 2023 1 | 19 | 24 | 43 |
| 2022 12 | 25 | 30 | 55 |
| 2022 11 | 25 | 28 | 53 |
| 2022 10 | 23 | 42 | 65 |
| 2022 9 | 27 | 35 | 62 |
| 2022 8 | 21 | 46 | 67 |
| 2022 7 | 22 | 43 | 65 |
| 2022 6 | 26 | 36 | 62 |
| 2022 5 | 28 | 51 | 79 |
| 2022 4 | 34 | 46 | 80 |
| 2022 3 | 37 | 48 | 85 |
| 2022 2 | 26 | 36 | 62 |
| 2022 1 | 52 | 40 | 92 |
| 2021 12 | 35 | 40 | 75 |
| 2021 11 | 37 | 50 | 87 |
| 2021 10 | 54 | 53 | 107 |
| 2021 9 | 46 | 46 | 92 |
| 2021 8 | 66 | 36 | 102 |
| 2021 7 | 41 | 38 | 79 |
| 2021 6 | 47 | 50 | 97 |
| 2021 5 | 46 | 50 | 96 |
| 2021 4 | 91 | 93 | 184 |
| 2021 3 | 41 | 33 | 74 |
| 2021 2 | 35 | 17 | 52 |
| 2021 1 | 24 | 18 | 42 |
| 2020 12 | 26 | 15 | 41 |
| 2020 11 | 17 | 21 | 38 |
| 2020 10 | 15 | 8 | 23 |
| 2020 9 | 37 | 22 | 59 |
| 2020 8 | 22 | 21 | 43 |
| 2020 7 | 28 | 21 | 49 |
| 2020 6 | 30 | 18 | 48 |
| 2020 5 | 24 | 21 | 45 |
| 2020 4 | 24 | 19 | 43 |
| 2020 3 | 15 | 11 | 26 |
| 2020 2 | 1 | 0 | 1 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 6 | 0 | 6 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 1 | 1 | 2 |
| 2018 4 | 23 | 16 | 39 |
| 2018 3 | 21 | 16 | 37 |
| 2018 2 | 10 | 8 | 18 |
| 2018 1 | 11 | 2 | 13 |
| 2017 12 | 11 | 7 | 18 |
| 2017 11 | 17 | 6 | 23 |
| 2017 10 | 24 | 14 | 38 |
| 2017 9 | 14 | 4 | 18 |
| 2017 8 | 12 | 7 | 19 |
| 2017 7 | 8 | 9 | 17 |
| 2017 6 | 29 | 8 | 37 |
| 2017 5 | 29 | 9 | 38 |
| 2017 4 | 22 | 7 | 29 |
| 2017 3 | 18 | 3 | 21 |
| 2017 2 | 10 | 5 | 15 |
| 2017 1 | 15 | 7 | 22 |
| 2016 12 | 23 | 14 | 37 |
| 2016 11 | 19 | 8 | 27 |
| 2016 10 | 31 | 6 | 37 |
| 2016 9 | 26 | 7 | 33 |
| 2016 8 | 15 | 6 | 21 |
| 2016 7 | 8 | 2 | 10 |
| 2016 6 | 0 | 9 | 9 |
| 2016 4 | 1 | 0 | 1 |
| 2016 2 | 2 | 15 | 17 |
| 2015 12 | 9 | 0 | 9 |
| 2015 10 | 3 | 17 | 20 |
| 2015 9 | 2 | 0 | 2 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 20 | 5 | 25 |
| 2015 6 | 22 | 6 | 28 |
| 2015 5 | 38 | 23 | 61 |
| 2015 4 | 30 | 19 | 49 |
| 2015 3 | 36 | 19 | 55 |
| 2015 2 | 20 | 10 | 30 |
| 2015 1 | 23 | 11 | 34 |
| 2014 12 | 32 | 12 | 44 |
| 2014 11 | 13 | 12 | 25 |
| 2014 10 | 21 | 10 | 31 |
| 2014 9 | 11 | 12 | 23 |
| 2014 8 | 21 | 15 | 36 |
| 2014 7 | 24 | 33 | 57 |
| 2014 6 | 34 | 11 | 45 |
| 2014 5 | 28 | 17 | 45 |
| 2014 4 | 24 | 15 | 39 |
| 2014 3 | 43 | 27 | 70 |
| 2014 2 | 39 | 11 | 50 |
| 2014 1 | 47 | 16 | 63 |
| 2013 12 | 32 | 11 | 43 |
| 2013 11 | 21 | 11 | 32 |
| 2013 10 | 38 | 22 | 60 |
| 2013 9 | 32 | 16 | 48 |
| 2013 8 | 45 | 22 | 67 |
| 2013 7 | 34 | 16 | 50 |
| 2013 6 | 30 | 18 | 48 |
| 2013 5 | 26 | 16 | 42 |
| 2013 4 | 26 | 24 | 50 |
| 2013 3 | 25 | 23 | 48 |
| 2013 2 | 32 | 21 | 53 |
| 2013 1 | 23 | 17 | 40 |
| 2012 12 | 32 | 21 | 53 |
| 2012 11 | 12 | 26 | 38 |
| 2012 10 | 9 | 20 | 29 |
| 2012 9 | 8 | 5 | 13 |
| 2012 7 | 1 | 0 | 1 |
| 2012 6 | 2 | 0 | 2 |
| 2012 5 | 1 | 0 | 1 |
| 2012 4 | 6 | 0 | 6 |
| 2012 3 | 2 | 0 | 2 |
| 2012 2 | 2 | 0 | 2 |
| 2012 1 | 2 | 0 | 2 |
| 2011 12 | 6 | 0 | 6 |
| 2011 11 | 3 | 0 | 3 |
| 2011 10 | 2 | 0 | 2 |
| 2011 9 | 1 | 0 | 1 |
| 2011 7 | 1 | 0 | 1 |
| 2011 6 | 1 | 0 | 1 |
| 2011 5 | 2 | 0 | 2 |
| 2011 2 | 1 | 0 | 1 |
| 2011 1 | 12 | 0 | 12 |
Show all
